Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease
about
Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysisFecal calprotectin in inflammatory bowel diseaseThe role of calprotectin in pediatric diseaseCalprotectin: Clinical Applications in PediatricsComparison of three tests for faecal calprotectin in children and young adults: a retrospective monocentric study.High-sensitivity C-reactive protein in paediatric inflammatory bowel disease.The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease.The role and utility of faecal markers in inflammatory bowel disease.Fecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis.Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levelsFecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation.Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.Progress in the treatment and outcome of pediatric inflammatory bowel disease patients.Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitisAre faecal markers good indicators of mucosal healing in inflammatory bowel disease?Utility of faecal calprotectin analysis in adult inflammatory bowel disease.Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease.Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel diseaseFecal calprotectin in juvenile idiopathic arthritis patients related to drug use.Calprotectin, calgranulin C, and other members of the s100 protein family in inflammatory bowel disease.Mucosal healing in Crohn's disease: a systematic review.Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.Monitoring of therapy for inflammatory bowel disease.Towards personalized care in IBD.Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.Biomarkers in management of inflammatory bowel disease.Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.Inflammatory Bowel Disease Incidence is on the Continuous Rise Among All Paediatric Patients Except for the Very Young: A Nationwide Registry-based Study on 28-Year Follow-up.Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.Assessment of disease activity in pediatric ulcerative colitis.Value of mucosal assessment and biomarkers in inflammatory bowel disease.C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease.Fecal calprotectin and clinical disease activity in pediatric ulcerative colitis.Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis.The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease.Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran.Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
P2860
Q24608254-CABAFB94-B97B-4CFC-8365-B255B33E416BQ26766527-91A1C7DE-B31C-4EAC-907A-7CF59FC8A510Q26852795-5F01C9AA-2DDC-473C-8029-0EF8D0074A5BQ28066517-8050CFC7-DB9E-4FC2-B5C7-9A22801D0B48Q33626018-36D1A551-7A01-4D1A-A7D9-351D49A4BB27Q33920587-E075B820-B1EA-46FC-8A82-3CD18B066B1CQ34344472-335AF8D2-9263-4C6D-BE17-C92597CA824BQ34406486-76DE5510-485C-405C-A1BC-8FDA0FABACF4Q34456258-463971D1-0282-4EE0-B2AF-1ADE4177EA93Q35157904-1796DCFA-7F5C-4CB9-83EF-CA1DEDC4163AQ35627273-0ADE2268-CBEB-4B2F-938C-87C38D53D855Q35634488-6402123C-A874-4900-A2FA-CE0F4C8850F2Q35670809-07AD8E5B-1C59-4F6D-B04A-5690854AC96EQ36056969-C8DC9E15-829D-4DC7-8627-22DDEC9EF010Q36166985-74D6FF4C-104E-4C28-9566-88DCCB7800E2Q36193147-0B1D6E45-0E9B-47F2-82D1-163E92EFB122Q36461010-425CF100-FE7D-467D-A37C-34FA903A057AQ36699209-45931158-104C-49C8-B39C-B4063E81D3E5Q37064590-48DC8CC8-BA60-4807-BF61-7318BDB8FA50Q37352180-F7AA3885-C70C-4639-A211-367963AC3EB1Q37618733-1722D899-5310-4366-8868-3081CB2FF864Q37825812-E6F3026C-47C2-473E-9563-3CD64D89144BQ38005972-0654A6F8-D6FA-46E1-9485-365C1A3F4E2CQ38035199-8CA1F706-9052-47C5-AA77-03E704760565Q38050877-AB483BE6-A14C-40FF-B691-41409ECE93A4Q38171924-D1D0D324-B631-4BD4-91CE-194ADC150448Q38180530-BD7CB9A4-FDA9-4D6B-910E-D47705F75288Q38215501-235D930D-BF28-4E6B-AFB6-D5604FA3FB90Q38219444-50E15175-C6E4-4C49-AD84-1A4BE553D15EQ38405987-3699ABBA-A8F0-4CAE-A23D-F843B600D526Q38625783-98F51F45-EA7C-4A62-8331-501EC42E1E71Q38742261-D51F012E-E10F-4744-A67D-3049DD6866EEQ38825374-C6E5EDE4-F609-48D5-A328-FDF1A0C497C9Q39866439-367D1E88-29F0-4DDD-A61A-DEA1E8599ED2Q41356664-E7A78777-B9F1-4755-AEAC-16AF58569976Q43226736-E975B0EB-A667-48B6-B2CF-AC91D81C2D29Q43308519-527086E7-889B-4925-A833-4BBCC1A962A4Q43590711-1FA1C5FD-C490-47F1-8829-AA7B1EBA2F34Q47550625-B4DB92AB-A7DA-4BA7-959D-738B66301A37Q47743116-1C019B55-4BB6-47D0-AA89-F284DF29F29E
P2860
Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease
description
im Januar 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2006
@uk
name
Fecal calprotectin remains hig ...... ith inflammatory bowel disease
@en
Fecal calprotectin remains hig ...... ith inflammatory bowel disease
@nl
type
label
Fecal calprotectin remains hig ...... ith inflammatory bowel disease
@en
Fecal calprotectin remains hig ...... ith inflammatory bowel disease
@nl
prefLabel
Fecal calprotectin remains hig ...... ith inflammatory bowel disease
@en
Fecal calprotectin remains hig ...... ith inflammatory bowel disease
@nl
P2860
P1476
Fecal calprotectin remains hig ...... ith inflammatory bowel disease
@en
P2093
Erkki Savilahti
Harry Lindahl
P2860
P304
P356
10.1080/00365520500419623
P577
2006-01-01T00:00:00Z